Allergan adds R&D facility in Massachusetts

Jan 14, 2019

Allergan announced it will establish an R&D presence in the Kendall Square section of Cambridge, Massachusetts.

The drugmaker says the new, strategic presence in Kendall Square will allow them to more easily interact and engage with venture firms and start ups in the area. The facility will be led by Don Frail, senior vice president of research and external scientific innovation and non-clinical translational sciences.

The new Cambridge group will be fully integrated with the Allergan organization, and serve as a portal to other R&D sites in Madison NJ, San Francisco area, and globally.

Read the press release

Want to get news like this in your inbox?  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments